nalidixic acid has been researched along with Kidney Diseases in 16 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
" Patients with a glomerular filtration rate of less than 30 ml/min require dosage reduction and we would recommend a reduction to half the usual dosage." | 1.27 | Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results. ( Asscher, AW; Hughes, PJ; Webb, DB, 1984) |
" The half-life of elimination depends on the molecular structure and varies between 2 and 10 h." | 1.27 | Pharmacokinetics: metabolism and renal excretion of quinolones in man. ( Baars, AM; Guelen, PJ; Hekster, YA; Vree, TB; Wijnands, WJ, 1986) |
" 5 Finally, the study of the urinary concentrations of NA and metabolites shows that a standard NA dosage can be used, at least in patients with mild renal insufficiency." | 1.26 | Nalidixic acid kinetics in renal insufficiency. ( Cuisinaud, G; Ferry, N; Pozet, N; Sassard, J; Zech, PY, 1982) |
" According to the different elimination mechanisms of the drugs investigated the kinetics was infleunced in different way by the restriction of the renal elimination of these drugs: The half-life periods for the elimination of Metindol, Nevigramon and Mebacid remained unchanged in patients with renal diseases; the half-value period for the elimination of Sulfaclomid was prolonged." | 1.26 | [Studies on the pharmacokinetics of Sulfaclomid, Mebacid, Nevigramon and Metindol in patients with reduced kidney function]. ( Stein, G; Traeger, A, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hughes, PJ | 1 |
Webb, DB | 1 |
Asscher, AW | 1 |
Cuisinaud, G | 1 |
Ferry, N | 1 |
Pozet, N | 1 |
Zech, PY | 1 |
Sassard, J | 1 |
Eichenwald, HF | 1 |
McCracken, GH | 1 |
Traeger, A | 1 |
Stein, G | 1 |
Miller, TE | 1 |
North, D | 1 |
Burnham, S | 1 |
Shimizu, M | 1 |
Takdase, Y | 1 |
Nakamura, S | 1 |
Katae, H | 1 |
Minami, A | 1 |
Vree, TB | 1 |
Wijnands, WJ | 1 |
Guelen, PJ | 1 |
Baars, AM | 1 |
Hekster, YA | 1 |
Alexander, S | 1 |
Forman, L | 1 |
Fairley, KF | 1 |
Jackson, EA | 1 |
McLeod, DC | 1 |
Stamey, TA | 1 |
Nemoy, NJ | 1 |
Higgins, M | 1 |
Kondás, J | 1 |
Lowentritt, LL | 1 |
Schlegel, JU | 2 |
Goff, JB | 1 |
O'Dell, RM | 1 |
Porpáczy, P | 1 |
Haschek, H | 1 |
Zischka-Konorsa, W | 1 |
Hermanek, P | 1 |
Bibus, B | 1 |
Gardaz, PC | 1 |
Genton, N | 1 |
1 review available for nalidixic acid and Kidney Diseases
Article | Year |
---|---|
Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Bacterial Infections; Cephalosporins; Child; Chi | 1978 |
15 other studies available for nalidixic acid and Kidney Diseases
Article | Year |
---|---|
Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
Topics: Anti-Infective Agents, Urinary; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kine | 1984 |
Nalidixic acid kinetics in renal insufficiency.
Topics: Adult; Biotransformation; Female; Humans; Hydroxylation; Kidney Diseases; Kinetics; Male; Middle Age | 1982 |
[Studies on the pharmacokinetics of Sulfaclomid, Mebacid, Nevigramon and Metindol in patients with reduced kidney function].
Topics: Creatine; Humans; Indomethacin; Kidney; Kidney Diseases; Nalidixic Acid; Pyrimidines; Sulfamerazine; | 1978 |
Acquiescent renal infection.
Topics: Animals; Escherichia coli Infections; Female; Gentamicins; Immunity; Kidney; Kidney Concentrating Ab | 1975 |
Pipemidic acid: its activities against various experimental infections.
Topics: Ampicillin; Animals; Anti-Infective Agents; Bacterial Infections; Carbenicillin; Cephalexin; Female; | 1976 |
Pharmacokinetics: metabolism and renal excretion of quinolones in man.
Topics: Anti-Infective Agents; Half-Life; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Kidney | 1986 |
Which of the drugs caused the rash? Or the value of the lymphocyte transformation test in eruptions caused by nalidixic acid.
Topics: Adult; Aged; Antibodies; Drug Eruptions; Female; Humans; Kidney Diseases; Lymphocyte Activation; Lym | 1971 |
Diagnosis and treatment of pyelonephritis.
Topics: Ampicillin; Bacterial Infections; Cephalexin; Erythromycin; Female; Gentamicins; Humans; Kidney Dise | 1973 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; H | 1974 |
The clinical use of nalidixic acid. A review and some observations.
Topics: Adult; Aged; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Female; Humans; In | 1969 |
Treatment of renal and urogenital infections with Nevigramon (nalidixic acid).
Topics: Bacterial Infections; Cystitis; Female; Humans; Kidney Diseases; Male; Nalidixic Acid; Prostatitis; | 1971 |
Treatment of bacteriuria in patients with impaired renal function.
Topics: Adolescent; Adult; Aged; Anuria; Bacteriuria; Female; Humans; Kidney Diseases; Kidney Function Tests | 1969 |
Urinary excretion of nalidixic acid, sulfamethizole and nitrofurantoin in patients with reduced renal function.
Topics: Adult; Aged; Bacteriuria; Creatine; Creatinine; Drug Resistance, Microbial; Female; Glomerular Filtr | 1968 |
[Nalidixic acid (Neggram) in the treatment of chronic non-specific urinary tract infections].
Topics: Adult; Aged; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Male; Middle Aged; Nalidix | 1968 |
[Nalidixic acid in treatment of postoperative urinary infections in pediatric urology and in long-term therapy of chronic pyelonephritis].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Female; Humans; Infant; | 1968 |